Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Placental weight: a new early warning sign for newborn blood sugar?

NCT ID NCT07765784

Diagnosis Sponsor: Kanuni Sultan Suleyman Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This study looks at whether the weight of the placenta, and its size relative to the baby's birth weight, can help predict low blood sugar (hypoglycemia) in newborns during the first 24 hours after birth. The study will include about 98 infants born at 35 weeks or later to mothers with gestational diabetes. Researchers will measure the infants' blood glucose levels at several time points after birth and compare these to placental measurements to see if there is a link.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Blood glucose level measurement
What this could lead to
If placental weight predicts newborn hypoglycemia, it could help identify at-risk infants earlier and guide monitoring after birth.
What could go wrong
This is a small, single-center study. The predictive value may be limited, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

98 people

The number who actually took part.

Started

Apr 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Newborn infants who are born to gestational diabetic mothers

Ages

0 hours to 2 days

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Infants born at the study center * a gestational age of ≥35 weeks * singleton pregnancies * maternal ages between 18 and 35 years Exclusion Criteria: * preterm birth (\<35 weeks of gestation) * referral to another center after delivery * presence of chromosomal and/or congenital anomalies * maternal conditions other than gestational diabetes * lack of parental consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypoglycaemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetic embryopathy hypoglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypoglycaemia Infants of diabetic mothers Placenta

Contacts and locations

Locations

  • University of Health Sciences GOP Training and Research Hospital

    Istanbul, Gaziosmanpasa, 34020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.